News UCB backs epilepsy-focused digital heath startup Nile AI Belgian drugmaker UCB has been steadily building its digital health expertise<
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face